Skip to main
CAH

Cardinal Health (CAH) Stock Forecast & Price Target

Cardinal Health (CAH) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 64%
Hold 9%
Sell 0%
Strong Sell 0%

Bulls say

Cardinal Health is well-positioned in the pharmaceutical wholesaler market, with a strong national distribution system and strategic partnerships in healthcare technology. Despite a recent impairment, their EPS estimates have been raised and they continue to invest in specialty and biologic therapies, indicating a positive outlook on future growth. Additionally, their focus on ESG performance and value-added services allows them to differentiate themselves in a highly competitive market, further contributing to their strength as a company. Their current valuation may be higher than historical levels, but is justified by their transition into a healthcare services and technology company with a strong presence in nuclear and precision health solutions.

Bears say

Cardinal Health is facing several challenges that could impact its future growth and profitability. These include a potential decrease in margins due to a shift towards specialty pharmaceuticals, potential changes in drug pricing and reimbursement systems, and a potential shift away from the buy-and-bill model in specialty distribution. Other risks for the company include exposure to energy and commodity costs, legal proceedings related to controlled substance distribution, and concentration of revenue from its largest customer, CVS. Despite some potential growth opportunities, such as expansion into specialty services and a strong distribution network, these challenges could hinder Cardinal Health's long-term outlook and competitiveness compared to its peers.

Cardinal Health (CAH) has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 64% recommend Buy, 9% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cardinal Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cardinal Health (CAH) Forecast

Analysts have given Cardinal Health (CAH) a Buy based on their latest research and market trends.

According to 11 analysts, Cardinal Health (CAH) has a Buy consensus rating as of Jun 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $231.55, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $231.55, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cardinal Health (CAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.